Cyclin-dependent kinases as a therapeutic target for stroke

AUTOR(ES)

Osuga, Hitoshi

FONTE

The National Academy of Sciences

RESUMO

Cyclin-dependent kinases (CDKs) are commonly known to regulate cell proliferation. However, previous reports suggest that in cultured postmitotic neurons, activation of CDKs is a signal for death rather than cell division. We determined whether CDK activation occurs in mature adult neurons during focal stroke in vivo and whether this signal was required for neuronal death after reperfusion injury. Cdk4/cyclin D1 levels and phosphorylation of its substrate retinoblastoma protein (pRb) increase after stroke. Deregulated levels of E2F1, a transcription factor regulated by pRb, are also observed. Administration of a CDK inhibitor blocks pRb phosphorylation and the increase in E2F1 levels and dramatically reduces neuronal death by 80%. These results indicate that CDKs are an important therapeutic target for the treatment of reperfusion injury after ischemia.

Documentos Relacionados

• Transcriptional activating regions target a cyclin-dependent kinase
• A cell cycle-regulated inhibitor of cyclin-dependent kinases.
• Activation of human cyclin-dependent kinases in vitro.
• Inhibition of cyclin-dependent kinases by p21.
• Cyclin-Stimulated Binding of Cks Proteins to Cyclin-Dependent Kinases